These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 188635)

  • 1. Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.
    Fushimi H; Kobayashi Y; Koyama T; Miyata M; Yamada T; Matsuyuki Y; Sugase T; Shima K; Tarui S
    Endocrinol Jpn; 1976 Oct; 23(5):423-8. PubMed ID: 188635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
    Robertson RP; Porte D
    J Clin Invest; 1973 Apr; 52(4):870-6. PubMed ID: 4693651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic modulation of pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Noacco C; Schneider V; Forsham PH
    J Clin Invest; 1974 May; 53(5):1441-6. PubMed ID: 4825234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
    Hirsch IB; Boyle PJ; Craft S; Cryer PE
    Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension.
    Messerli FH; Kuchel O; Hamet P; Tolis G; Guthrie GP; Fraysse J; Nowaczynski W; Genest J
    Circ Res; 1976 Jun; 38(6 Suppl 2):42-7. PubMed ID: 178467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion.
    Kaneto A; Miki E; Kosaka K
    Endocrinology; 1975 Nov; 97(5):1166-73. PubMed ID: 241626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
    Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
    J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
    Flaten O; Sand T; Myren J
    Scand J Gastroenterol; 1982 Mar; 17(2):283-8. PubMed ID: 6127792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    J Clin Endocrinol Metab; 1979 Feb; 48(2):302-8. PubMed ID: 429484
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose counterregulation during recovery from neuroglucopenia: which mechanism is important?
    Asplin CM; Raghu PK; Koerker DJ; Palmer JP
    Metabolism; 1985 Jan; 34(1):15-8. PubMed ID: 2857049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.